Register for our S/EIS Fund

o2h ChaiTime

  • webinar-banner webinar-banner

    Countdown to Tax Year End – Britain’s Startup Ecosystem

  • webinar-banner webinar-banner

    Next Wave of Britain’s Most Exciting Biotechs- From Small Molecule to Quantum Computing…

more about ChaiTime
more about ChaiTime
Filters
Season
Topics
  • culture and community
  • discovery
  • technology
  • ventures
No data found
Countdown to Tax Year End – Britain’s Startup Ecosystem

Countdown to Tax Year End – Britain’s Startup Ecosystem

Patrick Beldon,
Martin Taylor,
Mark Brownridge,
Kirsty Greenwood (moderator)
S3: EP2
4:00 PM BST, 19th March 2021
Has the Pandemic been a tailwind for Biotech investing?

Has the Pandemic been a tailwind for Biotech investing?

Sam Fazeli,
Sunil Shah (moderator)
S3: Ep1
4:00 PM BST, 5th March 2021
The Drug Hunters – Christmas Special

The Drug Hunters – Christmas Special

Peter Hamley,
Karin Briner,
Hemal Soni,
Christopher Smith,
Sunil Shah (moderator)
S2: Ep12
3:00 PM BST, 18th Dec 2020
Next Wave of Britain’s Most Exciting Biotechs- From Small Molecule to Quantum Computing…

Next Wave of Britain’s Most Exciting Biotechs- From Small Molecule to Quantum Computing…

Dr. Vid Stojevic,
Dr. Tim Sparey,
Dr. Myriam Ouberai,
Dr Andy Richards (moderator)
S2: Ep11
3:00 PM BST, 4th Dec 2020
Keeping the Technology on the Fast-Track to Transform Healthcare

Keeping the Technology on the Fast-Track to Transform Healthcare

Stephanie Campbell,
Toby Clark,
Natalia Mateu,
Craig Townsend (moderator)
S2: Ep10
3:00 PM BST, 20th Nov 2020
Using Knowledge Intensive Investing to Spur the Growth of UK Biotech

Using Knowledge Intensive Investing to Spur the Growth of UK Biotech

Dr Andrew Woodland,
Dr Martin Hall,
Mark Brownridge,
Kirsty Greenwood (moderator)
S2: Ep9
3:00 PM BST, 6th Nov 2020
Research in Rare Diseases – The Scientists, New Technology and The Patients

Research in Rare Diseases – The Scientists, New Technology and The Patients

Michael Binks,
Nicola Miller,
Tim Guilliams,
Prashant Shah (moderator)
S2: Ep8
3:00 PM BST, 23rd Oct 2020
The Virtualization of Biotechnology to Deliver Superior Investor Returns

The Virtualization of Biotechnology to Deliver Superior Investor Returns

Dr. Matt Cooper,
Dr. Harren Jhoti,
Professor Chas Bountra ,
Sunil Shah (moderator)
S2: Ep7
3:00 PM BST, 9th Oct 2020
From PHD to CEO, Entrepreneur War Stories from the Front Line

From PHD to CEO, Entrepreneur War Stories from the Front Line

Fiona Neilson,
Will Bateman,
Oliver Armitage,
Myriam Ouberai,
Prashant Shah (moderator)
S2: Ep6
3:00 PM BST, 25th Sept 2020
AI and Drug Discovery

AI and Drug Discovery

Dr. Hannah Sore,
Dr. Jerome Wicker,
Tina M. Larson,
Dr. Jackie Hunter (moderator)
S2: Ep5
3:00 PM BST, 11th Sept 2020
Learning the Lessons of Building Grapeshot and Exit to Oracle

Learning the Lessons of Building Grapeshot and Exit to Oracle

Max Bautin ,
John Synder,
Sunil Shah (moderator)
S2: Ep4
3:00 PM BST, 28th Aug 2020
Academic Spinouts – A UK and US Perspective…

Academic Spinouts – A UK and US Perspective…

Vinit Nijhawan,
Peter Lane,
Dr. Christine Martin,
Sunil Shah (moderator)
S2: Ep3
3:00 AM BST, 17th Aug 2020
The Best of American and British Entrepreneurs to Build a Successful Biotech Therapeutic Venture

The Best of American and British Entrepreneurs to Build a Successful Biotech Therapeutic Venture

Rosamond Deegan,
Jennifer Petter,
Sunil Shah (moderator)
S2: Ep1
3:00 PM BST, 17th July 2020
The Emerging World of Digital Therapeutics

The Emerging World of Digital Therapeutics

Nigel Pitchford,
Guillem Singla Buxarrai,
Shamus Hushee,
Patrick Beldon,
Sunil Shah (moderator)
S1: Ep10
3:00 PM BST, 26th June 2020
Building a Diversified Portfolio Post Covid19

Building a Diversified Portfolio Post Covid19

Luke Hakes,
Madison Faller,
Sunil Shah (moderator)
S1: Ep9
3:00 PM BST, 19th June 2020
Faster Cancer Drugs to Patients

Faster Cancer Drugs to Patients

Chris Torrance,
Raj Chopra,
Niall Martin ,
Ruth Plummer ,
Ashok Venkitaraman (moderator)
S1: Ep8
3:00 PM BST, 12th June 2020
One-on-One Interview with the Author of “Building an Unconventional Biotech”

One-on-One Interview with the Author of “Building an Unconventional Biotech”

Blaise Lippa,
Sunil Shah (moderator)
S1: Ep7
3:00 PM BST, 5th June 2020
Antibiotic Resistance – The Fight for Humanity

Antibiotic Resistance – The Fight for Humanity

Ken Bradley,
Paul Finn,
Ankit Mahadevia,
Ajay Mistry,
Aleks Engel (moderator)
S1: Ep6
3:00 PM BST, 29th May 2020
Small Biotech and Big Pharma

Small Biotech and Big Pharma

Catherine Beech ,
Pete Adamson,
Sunil Shah (moderator)
S1 EP5
3:00 PM BST, 22 May 2020
Britain’s Most Exciting Human Health Companies

Britain’s Most Exciting Human Health Companies

Ruchi Sharma,
Peter Rands,
Sarah Howell,
Szabolcs Nagy,
Dr. Andy Richard (moderator)
S1: Ep4
3:00 PM BST, 15th May 2020
How to Build a Tech Business – From Funding, to Launch, to Exit!

How to Build a Tech Business – From Funding, to Launch, to Exit!

Ray Anderson,
Max Bautin,
Mark Warne,
Kamil Tamiola,
Fiona Nielsen,
Craig Townsend (moderator)
S1: Ep3
3:00 PM BST, 7th May 2020
Innovate from Your Sofa

Innovate from Your Sofa

Christoph Loch,
Karin Briner,
Chris Heron,
Lekha Washington,
Prashant Shah (moderator)
S1: EP2
3:00 PM BST, 1st May 2020
Early Stage Investing in a Post COVID19 Pandemic Environment

Early Stage Investing in a Post COVID19 Pandemic Environment

Kieran Murphy,
Peyman Gifani,
Goncalo de Vasconcelos,
Sanjeev Gordhan,
Steve Thurlby,
Deepali Nangia,
Sunil Shah (moderator)
S1: Ep1
3:00 PM BST, 24th April 2020

o2h ChaiTime Webinars

During the British lockdown fight we decided to bring our ‘hot network’ together through a series of lively ChaiTime webinars. They have been a steaming success with around 200 registrations for each one and close to 150 live viewers.

We discussed various interesting subjects from ‘Early Stage Investing in Post Covid-19 Environment’ to ‘Building a Billion Dollar Biotech’. Panelists / Chairs included Kieran Murphy, CEO of GE Healthcare; Andy Richards, Biotech Investor and Entrepreneur; Professor Christoph Loch, Director (Dean) of the University of Cambridge Judge Business School; Karin Briner, Vice President & Global Head of Chemistry at Novartis; Pete Adamson – VP, DAS Head, Ophthalmology, Johnson & Johnson Medical Ltd.

Register for Invitations